BEIJING and BRIDGEWATER, NJ., July 2, 2021 /PRNewswire/ — Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), announced positive Phase 1 clinical trial ...

Insulin is an essential medicine that helps the body turn food into energy and regulate blood sugar levels for millions of people with diabetes nationwide. That makes access to insulin vital for ...

Adocia, the clinical biopharmaceutical company focused on developing innovative formulations of approved proteins for the treatment of diabetes, announced positive topline results of a clinical study ...

October 9, 2012 (Berlin, Germany) — In a randomized, double-blind, comparator-controlled, 2-way crossover trial, 2 rapid-acting insulin analogs (lispro or aspart) formulated with recombinant human ...

Please provide your email address to receive an email when new articles are posted on . Novo Nordisk announced that it will offer “authorized generic” versions of ...

New insulin products were the go-to choice for U.S. adults with type 2 diabetes in the last half decade, researchers reported. According to a serial cross-sectional study of ambulatory insulin use ...

Please provide your email address to receive an email when new articles are posted on . Lilly announced Tuesday that it will offer “authorized generic” versions ...

The risk of cancer possibly increases if patients with diabetes use the long-acting insulin analogue glargine instead of human insulin. Scientists analysed the data of almost 130,000 patients with ...

The US Food and Drug Administration has approved rapid-acting insulin lispro-aabc injection 100 and 200 units/mL (Lyumjev, Eli Lilly) for the treatment of adults with type 1 and type 2 diabetes. The ...

Dr. Hirsch answers the question: 'Pros and Cons of Different Insulin Types?' — -- Question:What are the pros and cons of various types of insulins? Answer:I don't think we should think of insulin ...